Search Results - "Monkhorst K"

Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers.

Authors: van Putten J Snaebjornsson P Bosch LJW et al.

Source: Nature medicine [Nat Med] 2026 Apr; Vol. 32 (4), pp. 1555.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; In Process

Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancer.

Authors: Radonic T Rahmani-Khajouei S Dafni U et al.

Corporate Authors: Radonic T Rahmani-Khajouei S Dafni U et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2026 Aug; Vol. 218, pp. 109514. Date of Electronic Publication: 2026 Jun 28.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

The persistence and mortality of Lassa fever in Nigeria reflect systemic clinical and diagnostic challenges rather than viral reemergence alone.

Authors: Hammed, Opeyemi Adesina, Miracle Buoye, Busayo et al.

Source: Frontiers in Epidemiology. 2026, p1-4. 4p.

Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study.

Authors: Schuurbiers MMF Smith CG Hartemink KJ et al.

Corporate Authors: Schuurbiers MMF Smith CG Hartemink KJ et al.

Source: PLoS medicine [PLoS Med] 2025 Apr 15; Vol. 22 (4), pp. e1004574. Date of Electronic Publication: 2025 Apr 15 (Print Publication: 2025).

Publication Type: Journal Article; Validation Study

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE

External validation of a serum tumor marker algorithm for early prediction of no durable benefit to immunotherapy in metastastic non-small cell lung carcinoma.

Authors: Schuurbiers MMF van Delft FA Koffijberg H et al.

Source: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Tumour Biol] 2025 Jan-Dec; Vol. 47, pp. 14230380251316788. Date of Electronic Publication: 2025 Mar 17.

Publication Type: Journal Article; Validation Study

Journal Info: Publisher: SAGE Publications Country of Publication: United States NLM ID: 8409922 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0380 (Electronic) Linking ISSN: 10104283 NLM ISO Abbreviation: Tumour Biol Subsets: MEDLINE

The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC).

Authors: Gillis, Roni Zahavi, Tamar Peled, Nir et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1246. 15p.

Durable Marked Response of Unresectable Esophageal Squamous Cell Carcinoma After Radiotherapy Alone Followed by Combination Immunotherapy.

Authors: Watanabe, Yasuhiro Miyamoto, Shin′ichi Asano, Yoichi et al.

Source: Case Reports in Oncological Medicine. 2/27/2026, Vol. 2026, p1-5. 5p.

Enrichment of SMARCA4 mutations in lung carcinomas presenting as cancer of unknown primary.

Authors: Martinot T Schonewille LHN Ruano D et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2026 Aug; Vol. 218, pp. 109502. Date of Electronic Publication: 2026 Jun 19.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Optimising primary molecular profiling in non-small cell lung cancer.

Authors: Schouten RD Schouten I Schuurbiers MMF et al.

Source: PloS one [PLoS One] 2024 Jul 31; Vol. 19 (7), pp. e0290939. Date of Electronic Publication: 2024 Jul 31 (Print Publication: 2024).

Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Real-world clinical utility of tumor whole-genome sequencing in solid cancers.

Authors: van Putten J Snaebjornsson P Bosch LJW et al.

Source: Nature medicine [Nat Med] 2026 Apr; Vol. 32 (4), pp. 1286-1295. Date of Electronic Publication: 2026 Mar 20.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases.

Authors: Wessels PH Cornelissen S Monkhorst K et al.

Source: Breast (Edinburgh, Scotland) [Breast] 2026 Feb; Vol. 85, pp. 104674. Date of Electronic Publication: 2025 Dec 11.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

Transposable element expression is associated with sex chromosome number in humans.

Authors: Teoli, Jordan Merenciano, Miriam Fablet, Marie et al.

Source: PLoS Genetics. 6/26/2025, Vol. 21 Issue 6, p1-24. 24p.

FGF4 initiates X-chromosome inactivation via activating YY1 and prompting loss of pluripotency factors.

Authors: Ma L Fu W An L et al.

Source: The EMBO journal [EMBO J] 2026 May; Vol. 45 (9), pp. 3056-3072. Date of Electronic Publication: 2026 Mar 25.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE

RNA sequencing provides functional insights and diagnostic resolution in previously unsolved rare disease cases.

Authors: Lewis, Robert G. O'Shea, John M. Pizzo, Lucilla et al.

Source: BMC Medical Genomics. 11/14/2025, Vol. 18 Issue 1, p1-17. 17p.

Interfacial properties of monolayer PtSe2 FETs: A comparative study of traditional metal and semimetal electrodes.

Authors: Li, Songyang Li, Xu Chen, Jingjun et al.

Source: Applied Physics A: Materials Science & Processing. Jun2025, Vol. 131 Issue 6, p1-11. 11p.

Chinese expert consensus on the diagnosis and treatment of HER2‐altered non–small cell lung cancer.

Authors: Zhang, Shirong Wang, Wenxian Xu, Chunwei et al.

Source: Thoracic Cancer. Jan2023, Vol. 14 Issue 1, p91-104. 14p.

Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study.

Authors: Douma LH van der Noort V Lalezari F et al.

Source: The Lancet. Oncology [Lancet Oncol] 2025 Dec; Vol. 26 (12), pp. 1676-1684.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study.

Authors: van der Wel JWT Ernst SM Jebbink M et al.

Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Nov; Vol. 209, pp. 108783. Date of Electronic Publication: 2025 Sep 28.

Publication Type: Clinical Trial; Journal Article; Multicenter Study

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study.

Authors: Facheris, Giorgio Bruni, Alessio Nardone, Valerio et al.

Source: Biomolecules (2218-273X). Mar2026, Vol. 16 Issue 3, p423. 16p.

Pre-Existing Immunity Shapes Cancer Immunotherapy Efficacy.

Authors: Xagara, Anastasia Koinis, Filippos Tsapakidis, Konstantinos et al.

Source: Onco. Mar2026, Vol. 6 Issue 1, p4. 14p.